Urica Therapeutics

Miami, United States

Urica Therapeutics is a clinical-stage biopharmaceutical company developing pharmaceutical products to treat gout and kidney diseases.

$2.5M raised

Jan 2023

Seed

Biotechnology Health Care Life Science Medical

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Urica Therapeutics

How much funding has Urica Therapeutics raised?

Urica Therapeutics has raised $2.5M in total funding. The most recent round was Seed. The last funding was announced in January 2023.

Where is Urica Therapeutics headquartered?

Urica Therapeutics is headquartered in Miami, United States.

What does Urica Therapeutics do?

Urica Therapeutics is a clinical-stage biopharmaceutical company developing pharmaceutical products to treat gout and kidney diseases.

What stage is Urica Therapeutics at?

Urica Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 5, 2023.

MLA

"Urica Therapeutics — Funding & Investors." VCBacked, January 5, 2023, https://www.vcbacked.co/company/urica-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2023). Urica Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/urica-therapeutics

Wikipedia (cite web)

{{cite web |title=Urica Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/urica-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 5, 2023.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K